Skip to main content

Table 2 Demographic and clinical variables of the study groups and biochemical parameters in KDM individuals who are on metformin and non-metformin treatment

From: Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy

Study Demographics

TB-DM

KDM

 

Metformin

Non-metformin

No. of subjects recruited

11

11

Gender (Male/Female)

8/3

8/3

Median Age (Range)

50 (25–70)

48 (30–65)

BMI kg/m2

20.85 (15.5–28.6)

20.97 (13.8–26.1)

Diabetic Medications

Metformin

Insulin+Glimepiride

Smear Grade: 0/1+/2+/3+

0/3/4/4

0/1/6/4

Cavitary Disease (Y/N)

4/7

5/6

Lung Lesions (Unilateral/Bilateral)

7/4

6/5

Glycated hemoglobin level, %

11 (7.7–15.6)

10.2 (7.9–14.3)

  1. The values represent the geometric mean (and the 95% confidence intervals) except for age where the median (and the range) are depicted